Advanced HILIC Workflows for GLP-1 Agonist Impurity Profiling
DATE
FIRST SESSION: August 14, 2025
SECOND SESSION: October 7, 2025
Can’t make it to the live event? Register and we will send you the link so you can watch on demand.
TIME
FIRST SESSION: August 14, 2025
8:00 A.M. PDT, 11:00 A.M. EDT, 16:00 BST, 17:00 CEST
Duration: 60 Minutes
SECOND SESSION: October 7, 2025
12:30 P.M. IST, 9:00 A.M. CEST, 4:00 P.M. JST
Duration 60 Minutes
Overview
GLP-1 receptor agonists like Semaglutide and Tirzepatide are complex therapeutic peptides used in treating type 2 diabetes and obesity. Their structural complexity and formulation with diverse excipients pose significant analytical challenges. This webinar will explore impurity profiling and excipient analysis using orthogonal HILIC-UV/MS and HILIC-ELSD workflows.
Attendees will gain insights into mitigating nonspecific adsorption issues and improving method robustness using low-adsorption LC flow paths. The session will also highlight how these workflows complement traditional methods and support regulatory compliance through Analytical Quality by Design (AQbD) principles.
Key Learning Objectives:
Understand the structural and analytical challenges of GLP-1 receptor agonists.
Learn how HILIC-UV/MS and HILIC-ELSD workflows enhance impurity profiling.
Discover strategies to reduce nonspecific adsorption and improve recovery.
Please see Agilent’s privacy statement to learn more about how your personal data will be treated.
*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society and its sponsor via email. You understand that you can withdraw your consent at any time. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.